Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Mitchell

Concepts (452)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonectomy
43
2026
169
7.000
 Why?
Mycobacterium Infections, Nontuberculous
12
2026
366
3.650
 Why?
Anesthesiology
15
2026
175
3.500
 Why?
Thoracic Surgery
17
2026
144
3.170
 Why?
Esophageal Neoplasms
19
2025
349
2.590
 Why?
Lung Neoplasms
41
2025
2642
2.430
 Why?
Internship and Residency
18
2026
1257
2.270
 Why?
Thoracic Surgical Procedures
14
2025
94
2.200
 Why?
Clinical Competence
19
2025
1244
2.140
 Why?
Lung Diseases
10
2026
787
2.110
 Why?
Thoracic Surgery, Video-Assisted
12
2026
48
1.710
 Why?
Carcinoma, Non-Small-Cell Lung
18
2025
1182
1.560
 Why?
Anesthesiologists
3
2025
67
1.490
 Why?
Nontuberculous Mycobacteria
6
2024
208
1.470
 Why?
Educational Measurement
6
2025
326
1.460
 Why?
Echocardiography, Transesophageal
7
2022
133
1.440
 Why?
Esophagectomy
14
2024
135
1.390
 Why?
Education, Medical, Graduate
8
2025
557
1.330
 Why?
Postoperative Complications
29
2025
2920
1.290
 Why?
Surgeons
8
2026
340
1.140
 Why?
Anesthesia
5
2023
258
0.980
 Why?
Bronchiectasis
3
2012
112
0.960
 Why?
Perioperative Care
5
2025
231
0.910
 Why?
Tuberculosis, Pulmonary
3
2018
131
0.910
 Why?
Adenocarcinoma
8
2024
931
0.880
 Why?
Empyema, Pleural
2
2015
13
0.860
 Why?
Lung Transplantation
7
2019
338
0.860
 Why?
Societies, Medical
11
2025
887
0.830
 Why?
Humans
151
2026
144957
0.820
 Why?
Robotic Surgical Procedures
6
2024
182
0.820
 Why?
Neoplasm Staging
16
2025
1465
0.790
 Why?
Curriculum
7
2023
1060
0.720
 Why?
Central Venous Catheters
1
2022
53
0.680
 Why?
Catheterization, Central Venous
1
2022
123
0.620
 Why?
Physicians, Women
3
2026
88
0.610
 Why?
Minimally Invasive Surgical Procedures
6
2024
192
0.600
 Why?
Ultrasonography, Interventional
2
2018
160
0.600
 Why?
Teaching
3
2021
236
0.590
 Why?
Ischemic Preconditioning
3
2024
47
0.580
 Why?
Pleura
2
2024
28
0.520
 Why?
Thoracic Wall
1
2017
21
0.510
 Why?
Practice Guidelines as Topic
6
2017
1563
0.510
 Why?
Soft Tissue Infections
1
2017
39
0.500
 Why?
Abscess
1
2017
75
0.490
 Why?
Biomedical Research
4
2026
710
0.490
 Why?
Thoracoscopy
5
2020
62
0.490
 Why?
Bronchial Fistula
2
2015
4
0.480
 Why?
Databases, Factual
14
2025
1486
0.480
 Why?
Respiratory Tract Fistula
2
2015
7
0.480
 Why?
Pleural Diseases
2
2015
23
0.470
 Why?
Female
74
2026
78376
0.470
 Why?
Anastomosis, Surgical
3
2024
157
0.470
 Why?
Tomography, X-Ray Computed
10
2018
2738
0.470
 Why?
Male
69
2026
72406
0.460
 Why?
Thoracotomy
6
2019
83
0.460
 Why?
Laparoscopy
4
2024
475
0.460
 Why?
Pneumonia, Bacterial
2
2013
113
0.450
 Why?
Middle Aged
55
2026
35928
0.450
 Why?
Osteomyelitis
1
2017
143
0.440
 Why?
Aged
44
2025
25947
0.430
 Why?
Time-to-Treatment
3
2025
245
0.430
 Why?
Computer Simulation
5
2021
1026
0.420
 Why?
Computer-Assisted Instruction
1
2014
71
0.410
 Why?
Hypothermia
2
2025
52
0.410
 Why?
Retrospective Studies
30
2025
17101
0.400
 Why?
Chest Tubes
1
2013
34
0.400
 Why?
United States
27
2026
15988
0.390
 Why?
Equipment Contamination
1
2013
71
0.390
 Why?
Length of Stay
8
2024
1337
0.380
 Why?
Education, Medical
2
2026
276
0.380
 Why?
Tracheobronchomalacia
1
2012
15
0.380
 Why?
Internet
2
2014
700
0.380
 Why?
Treatment Outcome
20
2025
11695
0.380
 Why?
Tuberculosis, Multidrug-Resistant
1
2012
50
0.350
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1958
0.350
 Why?
Anti-Bacterial Agents
6
2024
1915
0.350
 Why?
Sputum
1
2013
308
0.340
 Why?
Pneumoperitoneum
1
2010
12
0.320
 Why?
Coronary Artery Bypass
2
2015
269
0.320
 Why?
Conversion to Open Surgery
2
2020
22
0.320
 Why?
Accreditation
3
2025
101
0.310
 Why?
Trachea
3
2022
261
0.310
 Why?
Prospective Studies
14
2024
7997
0.310
 Why?
Early Detection of Cancer
1
2015
466
0.310
 Why?
Combined Modality Therapy
6
2022
1268
0.310
 Why?
Faculty, Medical
2
2026
303
0.300
 Why?
Mass Screening
2
2015
1348
0.290
 Why?
Simulation Training
2
2021
134
0.290
 Why?
Specialties, Surgical
2
2023
82
0.280
 Why?
Heart Diseases
2
2022
350
0.270
 Why?
Cost of Illness
1
2010
321
0.270
 Why?
Small Cell Lung Carcinoma
2
2024
119
0.260
 Why?
Mycobacterium avium-intracellulare Infection
1
2008
63
0.260
 Why?
Workflow
2
2021
185
0.260
 Why?
Induction Chemotherapy
2
2024
87
0.250
 Why?
Pleural Neoplasms
2
2024
29
0.250
 Why?
Airway Obstruction
2
2022
162
0.240
 Why?
Diaphragm
2
2023
49
0.240
 Why?
Benchmarking
3
2023
188
0.240
 Why?
Prognosis
10
2025
4293
0.240
 Why?
Patient Satisfaction
1
2010
705
0.230
 Why?
Esophageal Diseases
1
2006
30
0.230
 Why?
Professionalism
1
2026
26
0.230
 Why?
Postoperative Care
3
2012
288
0.230
 Why?
Fever
1
2007
312
0.230
 Why?
Chemoradiotherapy
2
2024
239
0.230
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.230
 Why?
Anesthetics
2
2022
99
0.230
 Why?
Thoracic Neoplasms
1
2005
39
0.220
 Why?
Adult
30
2026
40506
0.220
 Why?
Organizational Culture
1
2026
162
0.210
 Why?
Genes, Plant
1
2024
46
0.210
 Why?
Vulnerable Populations
1
2025
177
0.210
 Why?
Certification
1
2025
119
0.210
 Why?
Magnoliopsida
1
2024
34
0.210
 Why?
Patient Readmission
3
2019
759
0.200
 Why?
Esophagogastric Junction
3
2024
56
0.200
 Why?
Esophageal Stenosis
1
2024
57
0.200
 Why?
Preoperative Care
3
2012
380
0.200
 Why?
Workplace
1
2026
274
0.200
 Why?
Carcinoma, Bronchogenic
1
2003
20
0.200
 Why?
Respiratory Paralysis
1
2023
4
0.200
 Why?
Interleukin-6
1
2007
780
0.190
 Why?
Mentors
1
2025
219
0.190
 Why?
Research
1
2026
431
0.190
 Why?
Plasmacytoma
1
2022
19
0.190
 Why?
Perception
1
2026
377
0.190
 Why?
Tracheal Neoplasms
1
2022
12
0.190
 Why?
Neoplasms, Second Primary
1
2024
100
0.190
 Why?
Guideline Adherence
2
2024
589
0.190
 Why?
Aged, 80 and over
13
2024
8279
0.190
 Why?
Bronchi
2
2007
267
0.180
 Why?
Cardiovascular Diseases
4
2019
2171
0.180
 Why?
Survival Rate
6
2025
2092
0.180
 Why?
Neoplasm Recurrence, Local
4
2024
1141
0.180
 Why?
Ascites
1
2002
49
0.180
 Why?
Propensity Score
3
2019
367
0.180
 Why?
Patient Selection
5
2015
719
0.180
 Why?
Endometriosis
1
2002
57
0.180
 Why?
Pleural Effusion
1
2002
60
0.180
 Why?
Pandemics
4
2025
1695
0.170
 Why?
Periodicals as Topic
1
2024
203
0.170
 Why?
Leukemia
1
2024
245
0.170
 Why?
Neoadjuvant Therapy
5
2024
463
0.170
 Why?
Credentialing
1
2021
21
0.170
 Why?
Social Determinants of Health
1
2025
301
0.170
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2021
20
0.170
 Why?
Interdisciplinary Research
1
2021
26
0.170
 Why?
Bronchoscopy
4
2012
227
0.160
 Why?
Technology
1
2021
96
0.160
 Why?
Leadership
1
2025
409
0.160
 Why?
Sarcoma
1
2003
205
0.160
 Why?
Disease-Free Survival
4
2024
769
0.160
 Why?
Cardiovascular Abnormalities
1
2020
15
0.160
 Why?
Subclavian Artery
1
2020
28
0.160
 Why?
Carotid Artery, Common
1
2020
31
0.160
 Why?
Cohort Studies
6
2025
5965
0.160
 Why?
Education, Distance
1
2021
61
0.160
 Why?
Robotics
1
2021
87
0.160
 Why?
Developing Countries
1
2022
318
0.160
 Why?
Evolution, Molecular
1
2024
515
0.150
 Why?
Phylogeny
1
2024
1019
0.150
 Why?
Attitude of Health Personnel
2
2026
1186
0.150
 Why?
Anastomotic Leak
3
2024
44
0.150
 Why?
Educational Status
1
2021
467
0.150
 Why?
Stomach
3
2024
109
0.150
 Why?
Burnout, Professional
1
2026
484
0.140
 Why?
Metastasectomy
1
2018
19
0.140
 Why?
Genomics
1
2024
836
0.140
 Why?
Carcinoma, Squamous Cell
3
2012
642
0.140
 Why?
General Surgery
1
2021
207
0.140
 Why?
Quality of Life
3
2024
3192
0.140
 Why?
Pulmonary Emphysema
2
2015
275
0.140
 Why?
Manikins
1
2018
35
0.140
 Why?
Feasibility Studies
3
2018
1095
0.140
 Why?
Healthcare Disparities
1
2025
728
0.130
 Why?
Anesthesia, Cardiac Procedures
1
2017
27
0.130
 Why?
Forms and Records Control
1
2017
20
0.130
 Why?
Negative-Pressure Wound Therapy
1
2017
28
0.130
 Why?
Pylorus
1
2017
17
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Learning
1
2021
452
0.120
 Why?
Consensus
1
2018
489
0.120
 Why?
NADPH Oxidases
1
2017
124
0.120
 Why?
Antigen Presentation
1
2017
205
0.120
 Why?
Clinical Protocols
3
2024
282
0.120
 Why?
Pain Management
1
2020
405
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
154
0.120
 Why?
Neuromuscular Agents
1
2017
45
0.120
 Why?
Frailty
1
2019
198
0.120
 Why?
CD4-Positive T-Lymphocytes
2
2017
1129
0.120
 Why?
Botulinum Toxins, Type A
1
2017
58
0.120
 Why?
Program Development
1
2017
370
0.110
 Why?
Cause of Death
1
2017
472
0.110
 Why?
Patient-Centered Care
1
2020
544
0.110
 Why?
Documentation
1
2017
199
0.110
 Why?
Extracorporeal Membrane Oxygenation
1
2019
383
0.110
 Why?
Kidney Neoplasms
2
2009
412
0.110
 Why?
Radiotherapy Dosage
1
2015
289
0.110
 Why?
Pulmonary Disease, Chronic Obstructive
2
2015
923
0.110
 Why?
Forecasting
2
2026
391
0.110
 Why?
Risk Factors
7
2024
10792
0.110
 Why?
Chronic Disease
3
2017
1813
0.110
 Why?
Asphyxia
1
2014
23
0.110
 Why?
Risk
2
2015
911
0.100
 Why?
Chemotherapy, Adjuvant
2
2005
421
0.100
 Why?
Follow-Up Studies
4
2025
5417
0.100
 Why?
Dyspnea
2
2023
251
0.100
 Why?
Suture Techniques
2
2006
131
0.100
 Why?
Diabetes Mellitus
1
2022
1098
0.100
 Why?
Intubation, Intratracheal
1
2016
320
0.100
 Why?
Health Expenditures
1
2015
194
0.100
 Why?
Myocardial Infarction
1
2021
1209
0.100
 Why?
Perfusion
1
2014
250
0.100
 Why?
Group II Phospholipases A2
1
2012
10
0.090
 Why?
Carcinoma, Large Cell
1
2012
17
0.090
 Why?
Patient Discharge
1
2019
983
0.090
 Why?
Extensively Drug-Resistant Tuberculosis
1
2012
6
0.090
 Why?
Mutation
3
2022
4099
0.090
 Why?
Consumer Health Information
1
2013
49
0.090
 Why?
Radiography
1
2014
845
0.090
 Why?
Ultrasonography
1
2016
770
0.090
 Why?
Cardiology
1
2015
353
0.090
 Why?
Volatile Organic Compounds
1
2012
60
0.090
 Why?
Cost-Benefit Analysis
1
2015
636
0.090
 Why?
Time Factors
5
2024
7183
0.090
 Why?
B-Lymphocytes
1
2017
877
0.090
 Why?
ErbB Receptors
2
2022
629
0.090
 Why?
ras Proteins
1
2012
151
0.090
 Why?
Tracheal Stenosis
1
2012
39
0.090
 Why?
Smoking
2
2017
1472
0.090
 Why?
Physician's Role
1
2013
220
0.080
 Why?
Logistic Models
4
2019
2119
0.080
 Why?
Risk Assessment
4
2023
3676
0.080
 Why?
Cardiac Surgical Procedures
2
2017
609
0.080
 Why?
Morbidity
3
2023
323
0.080
 Why?
Mycobacterium Infections
1
2011
61
0.080
 Why?
Atrial Flutter
1
2011
45
0.080
 Why?
Antitubercular Agents
1
2012
216
0.080
 Why?
Tissue and Organ Procurement
1
2014
346
0.080
 Why?
Hemoptysis
1
2010
36
0.080
 Why?
Syndrome
1
2011
380
0.080
 Why?
Oxidative Stress
1
2017
1339
0.080
 Why?
Quality Improvement
4
2020
1291
0.080
 Why?
Neoplasm Invasiveness
3
2024
509
0.080
 Why?
Hospital Costs
1
2010
124
0.080
 Why?
Mycobacterium
1
2011
116
0.080
 Why?
DNA-Binding Proteins
1
2017
1500
0.070
 Why?
Carcinoma, Papillary
1
2009
79
0.070
 Why?
Teratoma
1
2010
120
0.070
 Why?
Proto-Oncogene Proteins
1
2012
623
0.070
 Why?
Patient Reported Outcome Measures
2
2024
489
0.070
 Why?
Enzyme Inhibitors
1
2012
826
0.070
 Why?
Kaplan-Meier Estimate
2
2023
966
0.070
 Why?
Transcription Factors
1
2017
1742
0.070
 Why?
Lymph Nodes
2
2023
502
0.070
 Why?
Reoperation
2
2008
631
0.070
 Why?
Carcinoid Tumor
1
2008
21
0.070
 Why?
Intraoperative Care
1
2008
62
0.070
 Why?
Mountaineering
1
2008
36
0.070
 Why?
Multivariate Analysis
3
2019
1540
0.070
 Why?
Stents
1
2012
556
0.070
 Why?
Spectral Karyotyping
1
2007
5
0.070
 Why?
Thrombectomy
1
2008
78
0.070
 Why?
Qualitative Research
2
2026
1671
0.070
 Why?
Registries
1
2016
2385
0.070
 Why?
Vena Cava, Inferior
1
2008
81
0.070
 Why?
Neoplasm, Residual
1
2008
139
0.070
 Why?
Positron-Emission Tomography
2
2009
343
0.070
 Why?
Respiratory Sounds
1
2008
105
0.070
 Why?
Li-Fraumeni Syndrome
1
2007
15
0.060
 Why?
Heart Failure
1
2021
2323
0.060
 Why?
Nephrectomy
1
2008
158
0.060
 Why?
Surgical Flaps
1
2008
142
0.060
 Why?
Chromosome Aberrations
1
2007
163
0.060
 Why?
Renal Dialysis
1
2011
462
0.060
 Why?
Barrett Esophagus
1
2009
165
0.060
 Why?
Urinary Bladder Neoplasms
1
2009
259
0.060
 Why?
Reproducibility of Results
3
2023
3415
0.060
 Why?
Cross-Sectional Studies
3
2026
5872
0.060
 Why?
Pyrimidines
1
2010
533
0.060
 Why?
Carbonic Anhydrases
1
2006
12
0.060
 Why?
Sulfonamides
1
2010
581
0.060
 Why?
Mediastinoscopy
1
2005
5
0.060
 Why?
Delivery of Health Care
1
2013
947
0.060
 Why?
Sialoglycoproteins
1
2006
158
0.060
 Why?
Vascular Surgical Procedures
1
2009
340
0.060
 Why?
Hyaluronan Receptors
1
2006
102
0.060
 Why?
Precancerous Conditions
1
2007
166
0.060
 Why?
Fatigue
2
2023
366
0.060
 Why?
Carcinoma, Renal Cell
1
2008
234
0.060
 Why?
Decision Making
1
2013
980
0.060
 Why?
Atrial Fibrillation
1
2011
550
0.060
 Why?
Sexism
1
2026
70
0.060
 Why?
Blood Loss, Surgical
1
2005
112
0.050
 Why?
Radiotherapy, Adjuvant
1
2005
222
0.050
 Why?
Hospital Mortality
2
2019
1031
0.050
 Why?
Heart-Lung Transplantation
1
2004
13
0.050
 Why?
Chylothorax
1
2004
20
0.050
 Why?
Antigens, Neoplasm
1
2006
272
0.050
 Why?
Odds Ratio
2
2019
1077
0.050
 Why?
Insulin Infusion Systems
1
2009
477
0.050
 Why?
Diagnosis, Differential
2
2010
1495
0.050
 Why?
Apoptosis
1
2012
2430
0.050
 Why?
Emergencies
1
2025
176
0.050
 Why?
Antineoplastic Agents
2
2012
2197
0.050
 Why?
Career Choice
1
2026
237
0.050
 Why?
Cytogenetic Analysis
1
2003
33
0.050
 Why?
Fossils
1
2024
77
0.050
 Why?
Job Satisfaction
1
2026
240
0.050
 Why?
Contraindications
1
2003
91
0.050
 Why?
Constriction, Pathologic
1
2024
248
0.050
 Why?
Evidence-Based Medicine
2
2017
732
0.050
 Why?
Biomarkers, Tumor
2
2007
1322
0.050
 Why?
Mesoderm
1
2003
150
0.050
 Why?
Airway Management
1
2022
79
0.040
 Why?
Advisory Committees
1
2023
230
0.040
 Why?
Lung
4
2024
4109
0.040
 Why?
Cell Survival
2
2017
1098
0.040
 Why?
Surveys and Questionnaires
2
2026
6053
0.040
 Why?
Sex Factors
1
2007
2114
0.040
 Why?
Learning Curve
1
2021
70
0.040
 Why?
Operating Rooms
1
2022
146
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2022
230
0.040
 Why?
Data Warehousing
1
2020
5
0.040
 Why?
Oxygen
1
2006
995
0.040
 Why?
Socioeconomic Factors
1
2024
1327
0.040
 Why?
Case-Control Studies
2
2024
3608
0.040
 Why?
Intermediate Care Facilities
1
2019
4
0.040
 Why?
Margins of Excision
1
2019
51
0.040
 Why?
Recurrence
1
2023
1135
0.040
 Why?
Survival Analysis
2
2017
1385
0.040
 Why?
Gene Expression Regulation, Neoplastic
3
2012
1462
0.040
 Why?
Cytokines
1
2007
2065
0.040
 Why?
Psychometrics
1
2023
734
0.040
 Why?
Walk Test
1
2019
80
0.040
 Why?
Imaging, Three-Dimensional
1
2003
583
0.040
 Why?
Nuclear Proteins
1
2024
749
0.040
 Why?
Serum Albumin
1
2019
147
0.040
 Why?
Radiography, Thoracic
2
2010
171
0.030
 Why?
Insulin
1
2009
2507
0.030
 Why?
Sarcopenia
1
2019
91
0.030
 Why?
Skilled Nursing Facilities
1
2019
151
0.030
 Why?
Lymphocyte Count
1
2017
164
0.030
 Why?
NADPH Oxidase 4
1
2017
8
0.030
 Why?
Antigen-Presenting Cells
1
2017
160
0.030
 Why?
Algorithms
1
2005
1839
0.030
 Why?
Glutathione Disulfide
1
2017
32
0.030
 Why?
Regression Analysis
1
2019
1003
0.030
 Why?
Gastric Emptying
1
2017
36
0.030
 Why?
Continuity of Patient Care
1
2019
292
0.030
 Why?
Geography
1
2017
203
0.030
 Why?
Incidence
1
2023
2883
0.030
 Why?
Patient Care Team
1
2022
689
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2022
988
0.030
 Why?
Immunophenotyping
1
2017
322
0.030
 Why?
Superoxides
1
2017
204
0.030
 Why?
Gastroepiploic Artery
1
2015
4
0.030
 Why?
Cytoplasm
1
2017
269
0.030
 Why?
Mammary Arteries
1
2015
8
0.030
 Why?
Home Care Services
1
2019
280
0.030
 Why?
Inflammation
1
2007
2880
0.030
 Why?
Writing
1
2017
100
0.030
 Why?
Academic Medical Centers
1
2018
548
0.030
 Why?
Radial Artery
1
2015
70
0.030
 Why?
Green Fluorescent Proteins
1
2017
405
0.030
 Why?
Task Performance and Analysis
1
2016
198
0.030
 Why?
Fluorescent Dyes
1
2017
330
0.030
 Why?
Adaptor Proteins, Signal Transducing
1
2017
428
0.030
 Why?
Lymphocyte Activation
1
2017
1126
0.020
 Why?
Focus Groups
1
2016
573
0.020
 Why?
Antioxidants
1
2017
549
0.020
 Why?
Solid Phase Microextraction
1
2012
7
0.020
 Why?
Oxidation-Reduction
1
2017
1087
0.020
 Why?
Tumor Microenvironment
1
2017
735
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2012
131
0.020
 Why?
Breath Tests
1
2012
79
0.020
 Why?
Gastroscopy
1
2012
18
0.020
 Why?
Young Adult
3
2014
14126
0.020
 Why?
Silicones
1
2012
29
0.020
 Why?
Foreign-Body Migration
1
2012
32
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
173
0.020
 Why?
Biomechanical Phenomena
1
2015
842
0.020
 Why?
Gene Expression Regulation, Enzymologic
1
2012
269
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2012
253
0.020
 Why?
Analgesics, Opioid
1
2020
1143
0.020
 Why?
Forced Expiratory Volume
1
2012
449
0.020
 Why?
Fibroblasts
1
2017
1034
0.020
 Why?
Gene Expression Profiling
2
2010
1786
0.020
 Why?
Lymphatic Metastasis
1
2012
334
0.020
 Why?
Device Removal
1
2012
143
0.020
 Why?
Debridement
1
2011
86
0.020
 Why?
False Positive Reactions
1
2011
122
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
983
0.020
 Why?
Artifacts
1
2011
139
0.020
 Why?
Air
1
2010
45
0.020
 Why?
Blotting, Western
1
2012
1187
0.020
 Why?
Global Health
1
2013
401
0.020
 Why?
Indazoles
1
2010
80
0.020
 Why?
Chest Pain
1
2010
100
0.020
 Why?
Adolescent
3
2014
22453
0.020
 Why?
Mice, Knockout
1
2017
3125
0.020
 Why?
Molecular Targeted Therapy
1
2012
434
0.020
 Why?
Photochemotherapy
1
2009
39
0.020
 Why?
Diarrhea
1
2010
192
0.020
 Why?
NF-kappa B
1
2012
662
0.020
 Why?
Drug Administration Schedule
1
2010
783
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
2032
0.020
 Why?
Phosphorylation
1
2012
1733
0.020
 Why?
Cisplatin
1
2009
334
0.020
 Why?
Administration, Oral
1
2010
848
0.020
 Why?
Gene Expression Regulation
1
2017
2609
0.020
 Why?
Esophagoscopy
1
2009
221
0.020
 Why?
Electrocardiography
1
2011
663
0.020
 Why?
Decompression, Surgical
1
2008
117
0.020
 Why?
Pilot Projects
1
2012
1890
0.020
 Why?
Suicide
1
2014
720
0.020
 Why?
Carbonic Anhydrase IX
1
2006
4
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2007
323
0.010
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.010
 Why?
Osteopontin
1
2006
34
0.010
 Why?
Tegafur
1
2005
12
0.010
 Why?
Platinum Compounds
1
2005
11
0.010
 Why?
Biomarkers
1
2017
4275
0.010
 Why?
Uracil
1
2005
36
0.010
 Why?
Lymphatic Diseases
1
2005
20
0.010
 Why?
Tracheal Diseases
1
2005
15
0.010
 Why?
Population Surveillance
1
2009
485
0.010
 Why?
Biopsy
1
2009
1077
0.010
 Why?
Catheter Ablation
1
2009
353
0.010
 Why?
Mediastinal Neoplasms
1
2005
51
0.010
 Why?
Drainage
1
2006
185
0.010
 Why?
Age Factors
1
2012
3335
0.010
 Why?
Meta-Analysis as Topic
1
2005
174
0.010
 Why?
Clone Cells
1
2005
266
0.010
 Why?
Kidney Failure, Chronic
1
2011
598
0.010
 Why?
Aminocaproates
1
2004
3
0.010
 Why?
Respiratory Mucosa
1
2007
322
0.010
 Why?
Cell Line, Tumor
1
2012
3550
0.010
 Why?
Lymphoma, Non-Hodgkin
1
2005
124
0.010
 Why?
RNA, Messenger
1
2012
2832
0.010
 Why?
Decision Trees
1
2004
81
0.010
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
758
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2005
331
0.010
 Why?
Mediastinum
1
2002
23
0.010
 Why?
Sensitivity and Specificity
1
2007
1990
0.010
 Why?
Hypertension
1
2010
1264
0.010
 Why?
Lymph Node Excision
1
2002
173
0.010
 Why?
Clinical Trials as Topic
1
2005
1054
0.010
 Why?
Cells, Cultured
1
2007
4155
0.010
 Why?
Blood Glucose
1
2009
2330
0.010
 Why?
Animals
1
2017
38109
0.010
 Why?
Mitchell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (452) concept(s)
_
Co-Authors Expand Description
See all (77) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)